BTSG Stock Analysis: Buy, Sell, or Hold?
BTSG - BrightSpring Health Services, Inc. Common Stock
$58.87
-0.66 (-1.11%)
▼
5d:
-4.6%
30d:
-15.71%
90d:
+1.52%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 31, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 19, 2026 at $59.33 · last confirmed Aug 19, 2026
Strength: 5.0/10
Get Alerted When BTSG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BTSG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BTSG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$110.91
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$68.87
14.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTSG is currently trading at $58.87, which is considered oversold relative to its 30-day fair value range of $59.93 to $70.49. The stock's valuation (Forward PE: 25.8) is in line with its historical norms (27.6). Remarkably, the market is currently pricing in an annual earnings decline of 2.2% over the next few years. This pessimistic expectation contrasts with the company's recent 196.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BTSG is in a strong uptrend. The price is currently testing key support at $57.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BTSG scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $78.94 (+34.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BTSG is in a strong uptrend. The price is currently testing key support at $57.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BTSG scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $78.94 (+34.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$59.93 -
$70.49
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding BTSG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.1% below Wall St target ($78.94)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$59.93 -
$70.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$57.40
Resistance Level
$62.89
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.84
Wall Street Target
$78.94
(+34.1%)
Revenue Growth (YoY)
23.0%
Earnings Growth (YoY)
196.6%
Profit Margin
2.5%
Valuation Discount vs History
-2.2% cheaper
PE vs Historical
25.8 vs 27.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.2%
(market-implied from PE analysis)
1-Year Target
$57.57
(-2%)
2-Year Target
$56.31
(-4%)
3-Year Target
$55.07
(-7%)
3-Yr Target (if PE normalizes)
(PE: 26→28)
$58.82
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.8, Growth: 25.2%)
$115.58
(+96%)
Base:
(SPY PE: 20.1, Growth: 25.2%)
$89.77
(+53%)
Bear:
(PE: 17.1, Growth: 25.2%)
$76.30
(+30%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Forward PE: 32.68 | Forward EPS (Implied): $1.80
Bull Case
$71.09
(+21%)
Analyst growth 15.0%, PE expands to 34.3
Base Case
$58.87
(0%)
Market implied 0.0%, PE stable at 32.7
Bear Case
$45.04
(-24%)
Severe decline -15.0%, PE contracts to 29.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.8 to 27.6
Stabilization Target:
$62.88
(+6.8%)
PE Expansion Potential:
+6.8%
Share & Embed Analysis
Last updated: August 23, 2026 7:29 PM ET
Data refreshes hourly during market hours. Next update: 8:29 PM
Data refreshes hourly during market hours. Next update: 8:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTSG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jennifer A Phipps
SELL
35000 shares
2026-03-04
Jon B Rousseau
SELL
220000 shares
2026-03-04
Lisa A Nalley
SELL
30000 shares
2026-03-04
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$254 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 41 HOLD |
Advanced BTSG Option Strategies
Professional options setups generated by AI based on today's BTSG price and gamma walls.
